title: The final answer? For the treatment of saphenous vein graft disease, drug-eluting stents vs. bare-metal stents.
authors.forename: Ichiro
authors.initials: I
authors.lastname: Michishita
mesh_terms: D017130:Angioplasty / Q000295:instrumentation*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000601:surgery; D023903:Coronary Restenosis / Q000188:drug therapy / Q000628:therapy*; D054855:Drug-Eluting Stents; D005500:Follow-Up Studies; D006083:Graft Occlusion, Vascular / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D015201:Meta-Analysis as Topic; D017239:Paclitaxel / Q000008:administration & dosage / Q000627:therapeutic use; D011183:Postoperative Complications / Q000401:mortality; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012501:Saphenous Vein / Q000187:drug effects / Q000473:pathology / Q000637:transplantation*; D020123:Sirolimus / Q000008:administration & dosage / Q000627:therapeutic use; D015607:Stents; D016896:Treatment Outcome
chemical_list: D017239:Paclitaxel; D020123:Sirolimus